InsiderTrades.com logo

TLIS Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 46.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Talis Biomedical Insider Trading History Chart

This chart shows the insider buying and selling history at Talis Biomedical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Talis Biomedical Share Price & Price History

Current Price: $2.84
Price Change: +0.30 (1.20%)
As of 03/12/2026 01:00 AM ET

This chart shows the closing price history over time for TLIS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Talis Biomedical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/3/2024Braden Michael LeonardMajor ShareholderBuy500$4.00$2,000.00218,602View SEC Filing Icon  
8/30/2024Braden Michael LeonardMajor ShareholderBuy151$4.25$641.75218,602View SEC Filing Icon  
8/28/2024Braden Michael LeonardMajor ShareholderBuy1,215$3.96$4,811.40217,951View SEC Filing Icon  
8/26/2024Braden Michael LeonardMajor ShareholderBuy13,167$3.90$51,351.30216,736View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Talis Biomedical (NASDAQ:TLIS)

43.77% of Talis Biomedical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TLIS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Talis Biomedical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/5/2024BML Capital Management LLC248,702$0.46M0.3%+481.9%13.665%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC42,743$0.32M0.2%N/A2.349%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.5,267$30K0.0%N/A0.289%Search for SEC Filing on Google Icon
5/17/2022Greenlight Capital Inc.2,235,783$3.15M0.2%+42.5%8.399%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd47,467$67K0.0%-19.8%0.178%Search for SEC Filing on Google Icon
2/14/2022Greenlight Capital Inc.1,569,300$6.29M0.4%N/A5.969%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd59,161$0.24M0.0%+153.9%0.225%Search for SEC Filing on Google Icon
2/4/2022Mercer Global Advisors Inc. ADV11,035$44K0.0%-44.9%0.042%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd59,161$0.24M0.0%+153.9%0.225%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Talis Biomedical logo
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
Read More on Talis Biomedical

Today's Range

Now: $2.84
Low: $2.84
High: $2.84

50 Day Range

MA: $2.15
Low: $1.60
High: $2.84

52 Week Range

Now: $2.84
Low: $1.04
High: $2.84

Volume

N/A

Average Volume

2,073 shs

Market Capitalization

$5.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Talis Biomedical?

Talis Biomedical's top insider investors include:
  1. Braden Michael Leonard (Major Shareholder)
Learn More about top insider investors at Talis Biomedical.